AMGN vs REGN
AMGN and REGN side by side — valuation & fundamentals (public data).
Key statistics
| Metric | AMGNAmgen Inc. | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| Market cap | $251.99B | — |
| P/E (TTM) | 29.0 | 20.5 |
| P/B | 21.56 | — |
| P/S | 6.9x | — |
| Dividend yield | 2.03% | — |
| Revenue | $38.09B(TTM) | $16.90B(TTM) |
| Revenue growth (YoY) | 10.0% | 1.0% |
| Net income | $8.74B(TTM) | $4.82B(TTM) |
| Earnings growth (YoY) | 88.5% | 2.1% |
| EPS, diluted | $16.10(TTM) | $45.24(TTM) |
| EBIT margin | 24.7% | 24.9% |
| ROE | 66.0% | 13.4% |
| ROIC | 15.1% | 9.2% |
| 1y total return | +62.9% | +41.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: AMGN frente a REGN
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)